Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer
NCT02524951
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
lack of interest by sponsor
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
MSI-1436C
Sponsor
Northwell Health
Collaborators
[object Object]